Income Statement NEXON Co., Ltd.

Equities

3659

JP3758190007

Internet Services

Market Closed - Japan Exchange Other stock markets 12:00:00 05/12/2025 pm IST			5-day change	1st Jan Change
3,763.00 ^JPY	-1.70%		-0.95%	+58.34%

25/11	NEXON Co., Ltd., Q3 2025 Earnings Call, Nov 11, 2025
12/11	Morgan Stanley Upgrades Nexon to Overweight from Equalweight; Price Target is 4,000 Yen	MT

c1d843ee7362536d0286c2.NQG7ByGTDmscMM3_Rj2dz-vtyPRx-AP-jpXTXD8mBxg.b0rLfnTwVAxEX4y5c3T7gpi-r44ptHbH__znBBJ5P3lfQ9w2Ffk_KClXiA

Published financial data: NEXON CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	29TCr	27TCr	35TCr	42TCr	45TCr
Total Revenues	29TCr	27TCr	35TCr	42TCr	45TCr
Cost of Goods Sold, Total	6.9TCr	7.21TCr	11TCr	14TCr	16TCr
Gross Profit	22TCr	20TCr	25TCr	29TCr	28TCr
Selling General & Admin Expenses, Total	8.19TCr	8.2TCr	11TCr	12TCr	11TCr
Provision for Bad Debts	-	-	-	558.9Cr	5.1Cr
R&D Expenses	1.65TCr	2.1TCr	2.59TCr	2.46TCr	2.49TCr
Depreciation & Amortization - (IS)	525.2Cr	544.4Cr	374.7Cr	430.7Cr	453.8Cr
Other Operating Expenses	-119.2Cr	-44Cr	-43Cr	-11Cr	82Cr
Other Operating Expenses, Total	10TCr	11TCr	14TCr	15TCr	14TCr
Operating Income	12TCr	9.43TCr	11TCr	13TCr	14TCr
Interest Expense, Total	-36Cr	-42Cr	-59Cr	-141Cr	-210.7Cr
Interest And Investment Income	827.5Cr	645.2Cr	1.3TCr	2.46TCr	2.4TCr
Net Interest Expenses	791.8Cr	603.7Cr	1.24TCr	2.32TCr	2.19TCr
Income (Loss) On Equity Invest.	76Cr	-100Cr	-1.02TCr	-351Cr	-517.9Cr
Currency Exchange Gains (Loss)	-1.77TCr	3.64TCr	4.17TCr	1.04TCr	3.09TCr
Other Non Operating Income (Expenses)	-19Cr	-39Cr	66Cr	9.5Cr	478.3Cr
EBT, Excl. Unusual Items	11TCr	14TCr	15TCr	16TCr	19TCr
Gain (Loss) On Sale Of Investments	125.4Cr	393.5Cr	-233.1Cr	211.6Cr	316.2Cr
Gain (Loss) On Sale Of Assets	-5.6Cr	-50L	-3.2Cr	-80L	-17Cr
Asset Writedown	-527.3Cr	-382.7Cr	-1.07TCr	-3.86TCr	225.1Cr
EBT, Incl. Unusual Items	11TCr	14TCr	14TCr	13TCr	20TCr
Income Tax Expense	5.27TCr	2.24TCr	4.05TCr	5.48TCr	5.98TCr
Earnings From Continuing Operations	5.55TCr	11TCr	10TCr	7.11TCr	14TCr
Net Income to Company	5.55TCr	11TCr	10TCr	7.11TCr	14TCr
Minority Interest	73Cr	182.2Cr	35Cr	-48Cr	-136.8Cr
Net Income - (IS)	5.62TCr	11TCr	10TCr	7.06TCr	13TCr
Net Income to Common Incl Extra Items	5.62TCr	11TCr	10TCr	7.06TCr	13TCr
Net Income to Common Excl. Extra Items	5.62TCr	11TCr	10TCr	7.06TCr	13TCr
Per Share Items
Net EPS - Basic	63.57	128.91	114.74	82.89	161.79
Basic EPS - Continuing Operations	63.57	128.91	114.74	82.89	161.79
Basic Weighted Average Shares Outstanding	88Cr	89Cr	87Cr	85Cr	83Cr
Net EPS - Diluted	61.9	126.55	113.81	82.33	161.09
Diluted EPS - Continuing Operations	61.9	126.55	113.81	82.33	161.09
Diluted Weighted Average Shares Outstanding	89Cr	90Cr	88Cr	86Cr	84Cr
Normalized Basic EPS	80.16	96.98	110.16	118.62	141.39
Normalized Diluted EPS	79.3	95.74	109.27	117.84	140.83
Dividend Per Share	5	7.5	10	10	22.5
Payout Ratio	7.86	3.87	8.76	12.15	7.63
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	13TCr	10TCr	12TCr	14TCr	15TCr
EBITA	12TCr	9.43TCr	11TCr	13TCr	14TCr
EBIT	12TCr	9.43TCr	11TCr	13TCr	14TCr
Effective Tax Rate - (Ratio)	48.7	16.54	28.85	43.55	30.5
Normalized Net Income	7.09TCr	8.64TCr	9.63TCr	10TCr	12TCr
Supplemental Operating Expense Items
Advertising Expense	2.04TCr	1.74TCr	2.57TCr	3.3TCr	2.87TCr
Selling and Marketing Expenses	2.7TCr	2.31TCr	3.28TCr	4.35TCr	4.05TCr
General and Administrative Expenses	185.4Cr	283.9Cr	448.3Cr	341.5Cr	87Cr
Research And Development Expense From Footnotes	1.65TCr	2.1TCr	2.59TCr	2.46TCr	2.49TCr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	25TCr	37TCr	41TCr	28TCr	33TCr
Short Term Investments	27TCr	17TCr	16TCr	32TCr	27TCr
Total Cash And Short Term Investments	53TCr	53TCr	57TCr	60TCr	60TCr
Accounts Receivable, Total	2.09TCr	1.76TCr	3.04TCr	3.79TCr	8.87TCr
Total Receivables	2.09TCr	1.76TCr	3.04TCr	3.79TCr	8.87TCr
Other Current Assets, Total	3.19TCr	4.12TCr	3.97TCr	5.49TCr	6.27TCr
Total Current Assets	58TCr	59TCr	64TCr	69TCr	75TCr
Net Property Plant And Equipment	3.42TCr	3.54TCr	4.6TCr	5.29TCr	6.34TCr
Long-term Investments	17TCr	26TCr	25TCr	24TCr	33TCr
Goodwill	3.84TCr	3.89TCr	4.01TCr	4.39TCr	4.46TCr
Other Intangibles, Total	1.49TCr	1.77TCr	965.5Cr	1.78TCr	3.48TCr
Deferred Tax Assets Long-Term	2.2TCr	3.82TCr	5.71TCr	5.59TCr	2.86TCr
Total Assets	86TCr	99TCr	1,04300Cr	1,09800Cr	1,25700Cr
Liabilities
Accounts Payable, Total	1.07TCr	935.4Cr	1.47TCr	1.63TCr	1.57TCr
Accrued Expenses, Total	687.5Cr	578.7Cr	1.02TCr	1.17TCr	2.82TCr
Short-term Borrowings	209.4Cr	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	265.7Cr	304.5Cr	404.5Cr	563.4Cr	712Cr
Current Income Taxes Payable	1.58TCr	1.66TCr	2.37TCr	1.79TCr	1.91TCr
Unearned Revenue Current, Total	1.15TCr	1.1TCr	1.89TCr	2.11TCr	2.39TCr
Other Current Liabilities	839.4Cr	751Cr	1.16TCr	1.67TCr	1.37TCr
Total Current Liabilities	5.8TCr	5.33TCr	8.31TCr	8.94TCr	11TCr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.18TCr	1.23TCr	1.93TCr	2.41TCr	3.29TCr
Deferred Tax Liability Non Current	5.11TCr	5.4TCr	5.04TCr	5.17TCr	5.94TCr
Other Non Current Liabilities	2.08TCr	2.12TCr	2.25TCr	2.63TCr	2.63TCr
Total Liabilities	14TCr	14TCr	18TCr	19TCr	23TCr
Common Stock, Total	2.27TCr	3.43TCr	3.9TCr	4.75TCr	5.08TCr
Additional Paid In Capital	1.74TCr	1.5TCr	1.83TCr	2.67TCr	3.01TCr
Retained Earnings	60TCr	71TCr	70TCr	71TCr	78TCr
Treasury Stock	-	-1.79TCr	-1.65TCr	-4.5TCr	-4.92TCr
Comprehensive Income and Other	7TCr	9.27TCr	11TCr	16TCr	21TCr
Total Common Equity	71TCr	84TCr	86TCr	90TCr	1,01900Cr
Minority Interest	1.06TCr	922.5Cr	935.3Cr	1.03TCr	1.15TCr
Total Equity	72TCr	85TCr	87TCr	91TCr	1,03100Cr
Total Liabilities And Equity	86TCr	99TCr	1,04300Cr	1,09800Cr	1,25700Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	89Cr	89Cr	86Cr	84Cr	82Cr
ECS Total Common Shares Outstanding	89Cr	89Cr	86Cr	84Cr	82Cr
Book Value / Share	800.35	939.19	996.95	1.06T	1.24T
Tangible Book Value	66TCr	78TCr	81TCr	83TCr	94TCr
Tangible Book Value Per Share	740.19	875.61	939.11	991.51	1.14T
Total Debt	1.66TCr	1.53TCr	2.33TCr	2.97TCr	4TCr
Net Debt	-51TCr	-52TCr	-55TCr	-57TCr	-56TCr
Minority Interest, Total (Incl. Fin. Div)	1.06TCr	922.5Cr	935.3Cr	1.03TCr	1.15TCr
Equity Method Investments, Total	519.5Cr	5.89TCr	8.36TCr	5.81TCr	6.37TCr
Full Time Employees	6.29T	6.68T	7.47T	8.23T	9.33T
Accumulated Allowance for Doubtful Accounts (Supple)	107.6Cr	106.5Cr	98Cr	87Cr	86Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	11TCr	14TCr	14TCr	13TCr	20TCr
Depreciation & Amortization - CF	857.4Cr	846.8Cr	676.7Cr	859.8Cr	1.01TCr
Depreciation & Amortization, Total	857.4Cr	846.8Cr	676.7Cr	859.8Cr	1.01TCr
(Gain) Loss From Sale Of Asset	965.5Cr	294.1Cr	533.7Cr	304Cr	1.34TCr
(Gain) Loss on Sale of Investments - (CF)	-438.2Cr	-70Cr	102.5Cr	3.97TCr	-1.88TCr
(Income) Loss On Equity Investments - (CF)	-76Cr	100Cr	1.02TCr	351Cr	517.9Cr
Other Operating Activities, Total	-1.48TCr	-3.65TCr	-4.02TCr	-5.78TCr	-4.27TCr
Change In Accounts Receivable	585.5Cr	481.6Cr	-896.8Cr	-451.6Cr	-5.38TCr
Change In Accounts Payable	269.1Cr	-146.6Cr	408.9Cr	95Cr	-304.1Cr
Change in Other Net Operating Assets	2.27TCr	-815.9Cr	1.13TCr	934.1Cr	-544.6Cr
Cash from Operations	14TCr	11TCr	13TCr	13TCr	10TCr
Capital Expenditure	-234.2Cr	-158.5Cr	-280.1Cr	-340.7Cr	-363.9Cr
Sale of Property, Plant, and Equipment	7.7Cr	6.8Cr	12Cr	4.1Cr	14Cr
Cash Acquisitions	-207.5Cr	-5.26TCr	-2.9TCr	-2.66TCr	-528.6Cr
Divestitures	5.5Cr	-	961Cr	13Cr	-
Sale (Purchase) of Intangible assets	-89Cr	-1.25TCr	-310.1Cr	-230.6Cr	-404.7Cr
Investment in Marketable and Equity Securities, Total	-13TCr	8.91TCr	2.15TCr	-15TCr	2.75TCr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-1Cr	-426.7Cr	-613Cr	-510.2Cr
Other Investing Activities, Total	-204.3Cr	-427.5Cr	-296.6Cr	-129.6Cr	-206.8Cr
Cash from Investing	-14TCr	1.81TCr	-1.09TCr	-19TCr	744.5Cr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-14Cr	-209.4Cr	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-14Cr	-209.4Cr	-	-	-
Issuance of Common Stock	705Cr	410.1Cr	602.3Cr	1.25TCr	444.1Cr
Repurchase of Common Stock	-278.3Cr	-1.6TCr	-9.88TCr	-7.9TCr	-5.46TCr
Common Dividends Paid	-441.7Cr	-444.1Cr	-878.5Cr	-857.9Cr	-1.03TCr
Common & Preferred Stock Dividends Paid	-441.7Cr	-444.1Cr	-878.5Cr	-857.9Cr	-1.03TCr
Other Financing Activities, Total	-233.9Cr	-258.5Cr	-427.3Cr	-343.3Cr	-435.9Cr
Cash from Financing	-262.6Cr	-2.11TCr	-11TCr	-7.86TCr	-6.48TCr
Foreign Exchange Rate Adjustments	419.1Cr	972.4Cr	3.08TCr	935.6Cr	778Cr
Net Change in Cash	-106.6Cr	11TCr	4.41TCr	-13TCr	5.14TCr
Supplemental Items
Cash Interest Paid	41Cr	42Cr	58Cr	140.5Cr	209.6Cr
Cash Income Tax Paid (Refund)	1.79TCr	3.76TCr	3.96TCr	5.42TCr	4.37TCr
Levered Free Cash Flow	8.72TCr	4.41TCr	8.61TCr	6.67TCr	4.57TCr
Unlevered Free Cash Flow	8.74TCr	4.44TCr	8.65TCr	6.76TCr	4.7TCr
Change In Net Working Capital	-609.9Cr	889.5Cr	-1.74TCr	1.79TCr	4.19TCr
Net Debt Issued / Repaid	-14Cr	-209.4Cr	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.6	6.37	6.72	7.72	7.34
Return on Total Capital	11	7.37	7.78	9.04	8.62
Return On Equity %	8.21	14.44	11.67	8.01	14.06
Return on Common Equity	8.45	14.86	11.84	8.05	14.08
Margin Analysis
Gross Profit Margin %	76.45	73.72	70.1	67.42	63.06
SG&A Margin	27.95	29.89	30.99	28.06	25.26
EBITDA Margin %	44.39	37.44	32.75	33.26	33.27
EBITA Margin %	41.46	34.35	30.83	31.23	31
EBIT Margin %	41.46	34.35	30.83	31.23	31
Income From Continuing Operations Margin %	18.94	41.2	28.27	16.79	30.53
Net Income Margin %	19.19	41.86	28.37	16.68	30.22
Net Avail. For Common Margin %	19.19	41.86	28.37	16.68	30.22
Normalized Net Income Margin	24.19	31.49	27.24	23.87	26.41
Levered Free Cash Flow Margin	29.74	16.07	24.34	15.75	10.25
Unlevered Free Cash Flow Margin	29.82	16.17	24.44	15.96	10.54
Asset Turnover
Asset Turnover	0.37	0.3	0.35	0.4	0.38
Fixed Assets Turnover	9.11	7.88	8.69	8.57	7.68
Receivables Turnover (Average Receivables)	11.82	14.25	14.73	12.39	7.05
Short Term Liquidity
Current Ratio	9.98	11.13	7.72	7.71	6.99
Quick Ratio	9.43	10.36	7.24	7.1	6.41
Operating Cash Flow to Current Liabilities	2.37	1.99	1.57	1.44	0.94
Days Sales Outstanding (Average Receivables)	30.96	25.61	24.78	29.45	51.92
Average Days Payable Outstanding	48.85	50.66	41.51	41.06	35.51
Long Term Solvency
Total Debt/Equity	2.3	1.81	2.69	3.28	3.88
Total Debt / Total Capital	2.25	1.78	2.62	3.17	3.74
LT Debt/Equity	1.64	1.45	2.22	2.66	3.19
Long-Term Debt / Total Capital	1.61	1.43	2.16	2.57	3.07
Total Liabilities / Total Assets	16.44	14.26	16.81	17.44	18
EBIT / Interest Expense	340.32	227.2	185.48	93.76	65.65
EBITDA / Interest Expense	364.34	247.6	196.99	99.85	70.46
(EBITDA - Capex) / Interest Expense	357.78	243.78	192.23	97.44	68.74
Total Debt / EBITDA	0.13	0.15	0.2	0.21	0.27
Net Debt / EBITDA	-3.91	-5.06	-4.74	-4.03	-3.78
Total Debt / (EBITDA - Capex)	0.13	0.15	0.21	0.22	0.28
Net Debt / (EBITDA - Capex)	-3.99	-5.14	-4.85	-4.13	-3.87
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.9	-6.33	28.88	19.69	5.4
Gross Profit, 1 Yr. Growth %	18.55	-9.68	22.53	15.12	-1.42
EBITDA, 1 Yr. Growth %	15.31	-21	12.73	21.55	5.45
EBITA, 1 Yr. Growth %	15.6	-22.4	15.67	21.21	4.63
EBIT, 1 Yr. Growth %	15.6	-22.4	15.67	21.21	4.63
Earnings From Cont. Operations, 1 Yr. Growth %	-51	103.76	-11.56	-28.91	91.63
Net Income, 1 Yr. Growth %	-51.39	104.35	-12.66	-29.63	90.98
Normalized Net Income, 1 Yr. Growth %	-17.63	21.93	11.47	4.88	16.63
Diluted EPS Before Extra, 1 Yr. Growth %	-51.66	104.45	-10.07	-27.66	95.66
Accounts Receivable, 1 Yr. Growth %	-26.91	-16.04	73.2	24.4	134.25
Net Property, Plant and Equip., 1 Yr. Growth %	13.71	3.54	29.72	14.99	19.88
Total Assets, 1 Yr. Growth %	19.9	14.44	5.7	5.3	14.45
Tangible Book Value, 1 Yr. Growth %	18.08	18.81	3.64	3.23	12.6
Common Equity, 1 Yr. Growth %	14.5	17.86	2.57	4.44	13.7
Cash From Operations, 1 Yr. Growth %	30.96	-23.03	22.88	-1.1	-21.56
Capital Expenditures, 1 Yr. Growth %	64.35	-32.32	76.72	21.64	6.81
Levered Free Cash Flow, 1 Yr. Growth %	8.98	-49.38	95.14	-22.52	-31.44
Unlevered Free Cash Flow, 1 Yr. Growth %	8.92	-49.21	94.83	-21.83	-30.38
Dividend Per Share, 1 Yr. Growth %	100	50	33.33	0	125
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.47	5.09	9.87	24.2	12.32
Gross Profit, 2 Yr. CAGR %	6.86	3.48	5.2	18.77	6.53
EBITDA, 2 Yr. CAGR %	7	-4.55	-5.63	17.05	13.21
EBITA, 2 Yr. CAGR %	6.49	-5.28	-5.25	18.41	12.62
EBIT, 2 Yr. CAGR %	6.49	-5.28	-5.25	18.41	12.62
Earnings From Cont. Operations, 2 Yr. CAGR %	-26.59	-0.08	34.24	-20.71	16.72
Net Income, 2 Yr. CAGR %	-27.74	-0.34	33.59	-21.6	15.93
Normalized Net Income, 2 Yr. CAGR %	-8.34	0.22	16.58	8.12	10.6
Diluted EPS Before Extra, 2 Yr. CAGR %	-28.07	-0.58	35.6	-19.34	18.97
Accounts Receivable, 2 Yr. CAGR %	-18.27	-21.66	20.59	46.79	70.71
Net Property, Plant and Equip., 2 Yr. CAGR %	16.61	8.51	15.9	22.13	17.41
Total Assets, 2 Yr. CAGR %	15.17	17.14	9.98	5.5	9.78
Tangible Book Value, 2 Yr. CAGR %	14.28	18.45	10.97	3.43	7.81
Common Equity, 2 Yr. CAGR %	13.07	16.17	9.95	3.5	8.97
Cash From Operations, 2 Yr. CAGR %	7.98	0.4	-2.75	10.24	-11.92
Capital Expenditures, 2 Yr. CAGR %	17.96	5.46	9.36	46.61	13.98
Levered Free Cash Flow, 2 Yr. CAGR %	8.95	-25.73	-0.61	22.96	-27.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.06	-25.62	-0.53	23.41	-26.23
Dividend Per Share, 2 Yr. CAGR %	-	73.21	41.42	15.47	50
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.64	2.65	12.48	13.05	17.59
Gross Profit, 3 Yr. CAGR %	7.91	1.04	9.48	8.41	11.62
EBITDA, 3 Yr. CAGR %	6.12	-3.29	0.89	2.68	13.05
EBITA, 3 Yr. CAGR %	5.65	-4.17	1.24	2.85	13.63
EBIT, 3 Yr. CAGR %	5.65	-4.17	1.24	2.85	13.63
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.61	3.16	-4.06	8.61	6.41
Net Income, 3 Yr. CAGR %	-0.31	2.19	-4.63	7.89	5.48
Normalized Net Income, 3 Yr. CAGR %	11.18	0.8	3.83	12.54	10.89
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.83	1.89	-3.85	9.98	8.38
Accounts Receivable, 3 Yr. CAGR %	-15.95	-17.54	2.05	21.85	71.54
Net Property, Plant and Equip., 3 Yr. CAGR %	7.82	12.08	15.16	15.59	21.38
Total Assets, 3 Yr. CAGR %	16.45	14.92	13.19	8.4	8.4
Tangible Book Value, 3 Yr. CAGR %	15.08	15.77	13.29	8.32	6.4
Common Equity, 3 Yr. CAGR %	15.13	14.64	11.45	8.08	6.79
Cash From Operations, 3 Yr. CAGR %	19.46	-3.54	7.39	-2.2	-1.58
Capital Expenditures, 3 Yr. CAGR %	4.49	-1.98	25.27	13.31	31.92
Levered Free Cash Flow, 3 Yr. CAGR %	15.24	-15.62	2.49	-8.53	1.21
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.31	-15.47	2.53	-8.21	1.97
Dividend Per Share, 3 Yr. CAGR %	-	-	58.74	25.99	44.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.02	8.43	8.53	10.78	12.42
Gross Profit, 5 Yr. CAGR %	9.77	8.43	6.82	7.79	8.29
EBITDA, 5 Yr. CAGR %	9.95	6.24	1.25	4.39	5.65
EBITA, 5 Yr. CAGR %	12.34	6.28	1.15	4.29	5.65
EBIT, 5 Yr. CAGR %	12.34	6.28	1.15	4.29	5.65
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.04	40.68	12.09	-7.14	3.76
Net Income, 5 Yr. CAGR %	0.39	41.67	12.07	-8.09	3.12
Normalized Net Income, 5 Yr. CAGR %	9.25	12.9	13.31	3.67	6.49
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.14	41.01	12.39	-7.2	4.7
Accounts Receivable, 5 Yr. CAGR %	-8.9	-8.25	-2.89	3.86	25.37
Net Property, Plant and Equip., 5 Yr. CAGR %	9.21	11.68	10.98	16	16.06
Total Assets, 5 Yr. CAGR %	15.16	17.43	13.82	11.06	11.81
Tangible Book Value, 5 Yr. CAGR %	14.64	17.5	13.42	10.67	11.07
Common Equity, 5 Yr. CAGR %	13.65	17.54	13.03	10.05	10.45
Cash From Operations, 5 Yr. CAGR %	18	7.64	10.02	1.75	-0.79
Capital Expenditures, 5 Yr. CAGR %	-4.04	-8.47	6.41	15.15	20.62
Levered Free Cash Flow, 5 Yr. CAGR %	16.23	-0.28	8.62	-1.9	-10.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.17	-0.17	8.69	-1.66	-10.12
Dividend Per Share, 5 Yr. CAGR %	0	24.57	-	-	55.18